Cite
HARVARD Citation
Rosenberg, J. et al. (n.d.). 21LBA Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210). European journal of cancer. pp. S720-. [Online].